| 3 min read
The new approach combined digital pathology with spatial proteomics to uncover the secrets of metastasis and personalized treatment options.
| 6 min read
A new AI analysis of a negative Alzheimer's trial raises questions about whether conventional clinical trials are missing patients who could still benefit from treatment.
| 3 min read
Scientists showed that a trio of medications successfully cleared the virus in a rhesus macaque infant model. Clinical testing in human infants could move quickly.News
| 4 min read
As non-opioid pain therapies continue to face setbacks, Insilico is using AI to uncover new biology and therapeutic targets.
| 3 min read
Brown University researchers found genetic variants linked to reduced malaria drug susceptibility, offering a new marker for resistance surveillance.
| 4 min read
Exciting clinical trial results, a new gene therapy moves forward, safety concerns, and more led the news this week.
| 5 min read
By combining genomics, brain imaging, and digital biomarkers, the MAP-D initiative aims to redefine depression through biology rather than symptoms alone.
| 3 min read
The newly approved drug vastly reduced the amount of antibodies that would usually lead to organ rejection in a patient who had no chance of receiving a matched transplant.
| 3 min read
A new intravaginal drug delivery platform has been selected to investigate whether localized UTI treatment can reduce the collateral effects of systemic antibiotics.
| 6 min read
Researchers are moving beyond the male default as evidence reveals how sex influences disease, drug response, and clinical outcomes.
| 4 min read
Two new FDA approvals, a CRISPR program discontinued, discussions of a major merger, and more led the news this week.
| 2 min read
A new alternative approach to antibody-drug conjugates takes advantage of cancer cells’ need for fuel — first by encouraging them to overdose on glucose and then by blocking its backup source of fat.
